P.A.T.H. Therapy’s Post

2023 brought positive results in a U.S. Phase 3 trial for fasedienol, our lead neuroactive pherine nasal spray for treatment of social anxiety disorder. The FDA granted a Fast Track designation for itruvone as a potential treatment for major depressive disorder. And PH80 demonstrated statistically significant improvement versus placebo in an exploratory Phase 2A study for acute management of the symptoms of premenstrual dysphoric disorder. 2024 has the potential to bring even more advancements to our pipeline of neuroactive pherine nasal sprays as we work to develop better, safer, and more effective treatment options for the millions of Americans living with central nervous system disorders. #SocialAnxietyDisorder #MentalHealth #InnovatingMentalHealth https://bit.ly/3Vyp8Pk

In specific cases, persons served may receive more intensive FDA-approved treatments to help with Major Depression, Anxious Depression, or Obsessive-Compulsive Disorder that has not responded to typical medication treatments. - SPRAVATO® (esketamine) is an FDA-approved, nasally administered medication that can be prescribed for adults with treatment-resistant depression or adults with major depressive disorder who have suicidal thoughts or actions. It is typically used along with an oral antidepressant and may only be prescribed after the individual has tried two or more oral antidepressants without experiencing a reduction in symptoms. - Deep brain rTMS (repetitive transcranial magnetic stimulation; pictured) is an FDA-approved intervention used to treat adults with treatment-resistant depression or treatment-resistant obsessive-compulsive disorder. The treatment utilizes electromagnetic currents to stimulate specific areas of the brain, which helps to reduce symptoms of depression or OCD. Read more about deep brain rTMS. These treatments are essential for persons who have not had the benefit of symptom relief by traditional medication interventions. Nearly all individuals experience a positive response from these interventions. ❤️ #CumminsHealth #MedicalServices #InterventionalMedicine #Spravato #TranscranialMagneticStimulation #TMS #IntegratedHealthcare #HolisticHealth #WholePersonCare #BehavioralHealthServices #CommunityHealth #HealthAndWellness

Psilocybin—The Next Frontier in Mental Health or the Next Target for Exploitation? As ketamine therapy faces increasing scrutiny, the spotlight is shifting to psilocybin, the active ingredient in “magic mushrooms,” which is emerging as a promising treatment for conditions like depression and PTSD. While the potential benefits of psilocybin are generating excitement, there’s also a growing concern about its exploitation in the healthcare sector. With regulatory frameworks still catching up, some providers may begin offering off-label or experimental psilocybin treatments, leading to unnecessary or even dangerous practices. This situation mirrors the early days of ketamine therapy, where rapid adoption outpaced oversight, resulting in inflated billing and misuse. #Psilocybin #MentalHealth #HealthcareFraud #EmergingTrends #PatientSafety

Do you know what the difference is between clinical depression and depressive syndrome? No? You can find the answer here: 💡Clinical depression lasts longer than two weeks and, according to the DSM-IV criteria, must fulfil at least five of the nine characteristic symptoms of depression. At least one of these symptoms must be a loss of pleasure and interests or a depressed mood. 💡Instead, a depressive syndrome is characterised by showing symptoms of depression, but for no longer than two weeks. ❗Due to the appearance of the same symptoms in both forms of depression, it is difficult to differentiate between clinical depression and depressive syndrome. Inexperienced general practitioners struggle to make a correct diagnosis, making it difficult for them to adhere to evidence-based guidelines. EQUAL CARE aims to raise awareness about such difficulties in the healthcare system and to overcome these types of harmful situations by promoting gender-sensitive medicine. #EQUALCAREnow #GenderMedicine #HealthcareGap #Equality #Psychology www.equal-care.org —————————————————————- Join EQUAL CARE today and lead the health market with our certification. Together, we can set a new standard for healthcare excellence and create a future where everyone receives the care they deserve. Let’s meet: https://lnkd.in/d592b7nB

Physical activity is 1.5 times more effective at reducing mild-to-moderate symptoms of depression, psychological stress, and anxiety than medication or cognitive behavior therapy, according to the study’s lead author, Dr. Ben Singh. A large new analysis of meta-studies finds that exercise is more beneficial for conditions such as anxiety and depression than standard psychotherapy or medications. The new study found that essentially all forms of exercise produced significant mental health benefits. Shorter, high intensity exercise programs produced the greatest effect. Exercise provided the greatest mental health benefit to people with depression, or who had been diagnosed with HIV and kidney disease, pregnant and postpartum women, and otherwise healthy adults. Full article via Medical News Today in comments below

🌟 BREAKTHROUGH: The FDA has approved Cobenfy™ (xanomeline and trospium chloride) for the treatment of schizophrenia in adults. Unlike traditional antipsychotics, #Cobenfy targets cholinergic receptors instead of dopamine, marking the first new approach to schizophrenia treatment in decades. Clinical trials showed a significant reduction in symptoms, offering new hope for those living with this chronic mental illness. Expect Cobenfy to hit the market by late October! Find the clinical evidence for Cobenfy at DRUGDOCS® : https://lnkd.in/eBbs3tv9 Read more from the FDA here: https://lnkd.in/gR_GWnSY #Schizophrenia #FDAApproval #MentalHealth #BristolMyersSquibb

Are you a new mom and suffering from postpartum depression? Worry not because there's no shame in experiencing postpartum depression. All you need to do is ask for help. With the right support and treatment, you can overcome this. If you are experiencing postpartum depression, it is important you talk to a healthcare professional or reach out to our pharmacists on: 📞 Adeola Odeku - 08188387165 📞 Lekki 1 - 08088526198 📞 Festac - 08078526190 For more content like this, kindly follow us @mopheth.ng #mopheth #postpartumdepression #healthiswealth #newmoms #lagosnigeria #explore #viralvideos #postpartumdepressionawareness

Our latest 📚 Research Brief from Chelsea Houghton, RN, MACP (In Progress) highlights the profound impact of CBT on symptoms of depression, anxiety, and quality of life of informal caregivers supporting individuals with diverse cancer diagnoses. Please share this insightful Feeling Good Institute research with your friends! 🖊 https://lnkd.in/gDUfuvC3 #CBT #cancersupport #anxiety #depression #research #therapy #therapist #LinkedinCommunity #LinkedinConnections #FeelingGoodInstitute

💜 April is PMDD Awareness Month💜 PMDD remains a widely misunderstood and underdiagnosed condition. Premenstrual dysphoric disorder (PMDD) is sometimes referred to as a very severe form of premenstrual syndrome (PMS). It is a cyclical, hormone-based disorder that can cause severe psychological and physical symptoms, including extreme mood swings, depression, irritability, and fatigue, during the premenstrual or luteal phase of the menstrual cycle. It can profoundly impact one’s life, relationships and wellbeing. There are options to help manage the symptoms of PMDD including medications such as SSRIs or hormonal treatments, lifestyle modifications, and psychotherapy. You can view Cilla’s experience with PMDD at https://lnkd.in/g6px5XqH Cilla is an advocate for HER Centre Australia, where you can learn more about PMDD and their most recent clinical research in this area. #PMDDAwarenessMonth #BreakTheStigma #mentalhealthawareness

Day 3 of #EuropeanMentalHealthWeek! 📊 34% Adolescents are at risk of developing clinical depression. 💪 4 sessions of 30 minutes a week of #TherapeuticExercise guided by a #Physiotherapist are effective in managing depressive disorder in adolescents. #BetterTogether